SOX17 reduces antitumor T-cell responses by decreasing MHC-I expression, thereby facilitating tumor cell immune evasion and promoting colon cancer initiation and progression.[84] In the context of tumor immune evasion, up-regulation of SOX4 is not only related to cell proliferation and survival but also affects antigen presentation by tumor cells. Here, SOX17 is linked to neoplasm.